Best Performing BioTech Stocks This Week – December 14, 2021

Companies in the biotechnology industry create medicines and diagnostic technologies for the treatment of illnesses and health conditions. If you’re searching for companies that can potentially lead to massive returns, the biotechnology business is a fantastic place to start.

Within this sector smaller start-ups with recent traction coexist with huge, well-established enterprises aiming to create a variety of medications and technology. Let’s review the best performing tech stocks this week.

5 Best BioTech Stocks This Week

There are several opportunities in the biotechnology business, but as with any industry, there are also plenty of risks. As a result, choosing the appropriate investments is just as essential as making the investments themselves.

Here are the 5 best biotech stocks to keep an eye on in the next months for significant gains.

1. Arena Pharmaceuticals, Inc. – Up 81.28%

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA). This is a biopharmaceutical business that specializes in the research, development, and marketing of new G protein-coupled receptor (GPCR) medications. Dominic P. Behan and Jack Lief formed the company on April 14, 1997, and it is based in San Diego, California.

This stock last closed at a price of $90.08 and is trading at an average volume of 2.063M.

2. Foghorn Therapeutics, Inc. – Up 47.46%

Foghorn Therapeutics, Inc. (NASDAQ: FHTX). This is a biopharmaceutical firm in the early stages of development. It is researching and developing a new class of precision medicine treatments for oncology that target the chromatin regulatory system.

This stock last closed at a price of $18.58 and is trading at an average volume of 2.12M.

3. BELLUS Health, Inc. – Up 40.98%

BELLUS Health, Inc. (NASDAQ: BLU). This is a biopharmaceutical development business that specializes in the discovery of innovative therapies for the treatment of chronic cough and other hypersensitization illnesses. The company was established on June 17, 1993, and is based in Laval, Quebec, Canada.

This stock last closed at a price of $8.30 and is trading at an average volume of 11.653M.

4. Molecular Partners AG – Up 11.75%

Molecular Partners AG (NASDAQ: MOLN). This firm specializes in the development of protein treatments for the treatment of critical diseases such as cancer and blindness. Christian Zahnd, Patrick Amstutz, Patrik Forrer, Andreas Plückthun, and Michael Tobias Stumpp started the company on November 22, 2004 in Schlieren, Switzerland.

This stock last closed at a price of $16.03 and is trading at an average volume of 39,138.

5. Selecta Biosciences, Inc. – Up 10.63%

Selecta Biosciences, Inc. (NASDAQ: SELB). This is a clinical-stage biopharmaceutical firm that specializes in nanoparticle immunomodulatory therapies for the treatment and prevention of human illnesses. It creates the Synthetic Vaccine Particles (SVP) platform, which is used to promote immunological tolerance and stimulation.

This stock last closed at a price of $3.21 and is trading at an average volume of 1.439M.

How To Buy BioTech Stocks

Investing in biotech stocks can be done in a few easy steps. In no time, you will be on your way to investing in some of the best performing biotech stocks.

1. Research Companies

It is critical to conduct research on any companies that you intend to invest in and add to your portfolio. Many investors are attracted to the Biotech industry due to its unparalleled stability and remarkable development potential.

In this sector you can invest in biotech funds in businesses that are developing next-generation medicines. Prospects in biotechnology stocks appear to be expanding all the time.

2. Select a Brokerage 

Before you get started investing, you need to select your preferred brokerage to work with. Here are some popular options for investing in biotech companies:

Features Brokers:

1. E*Trade — Free Stock Trading – Award winning platform and mobile app!
2. TradeStation — Also Free stock trading – intuitive stock trading tools. Cash bonus for new accounts (conditions apply).

• M1 Finance: This brokerage provides a mix of self-directed and automated trading and investing solutions. M1 Finance offers a low minimum deposit requirement and automatic investing for ordinary accounts at no added charge. More than 80 professional portfolios are available to you. Also, individual stock or ETF orders, as well as fractional shares, are accessible through M1 Finance. Sign up for M1 Finance here
• Merrill Edge: Merrill Edge’s portfolio analysis tools give a thorough examination of your assets. The mobile apps allow you to trade stocks, options, and mutual funds, but you cannot trade fixed income. Merrill Edge does not charge commissions on online stock, ETF, or OTCBB trades.
• Vanguard: Vanguard is an excellent option for traders because of its diverse fund selection. Vanguard charges a 0.3 percent annual fee and requires a minimum investment of $50,000. 

3. Open Your Trading Account

You must first create a trading account before you can begin investing in biotech stocks. Investigate each brokerage so that you may establish an account that includes everything you need to start making investments.

4. Make a Deposit & Purchase BioTech Stocks

After you’ve linked a valid payment method to your account, you’ll need to make a cash deposit before you can start buying biotech stocks. After your account has been fully authorized, you may begin investing.

5. Monitor Your Performance

After making an investment, it is important to keep track of the stocks in your portfolio on a frequent basis. Each brokerage offers its own set of stock screeners and tools to help you keep track of the details of each of your holdings.

Should You Invest in BioTech Stocks?

If you want to invest in the healthcare landscape, biotech stocks are a risky but possibly lucrative venture. They will also provide your portfolio with additional growth opportunities and can lead to excellent returns.

If you would like to start investing in biotechnology stocks then you should consider contacting a financial advisor.

Frequently Asked Questions

Investment Firms is a ready supported website. Our content is free to consume and most of the time we do not earn revenue from publishing articles. In some instances, clicking on links in articles may earn us a commission if you are to purchase something.